pentobarbital has been researched along with Retinal Diseases in 2 studies
Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.
Retinal Diseases: Diseases involving the RETINA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bell, BA | 1 |
| Bonilha, VL | 1 |
| Hagstrom, SA | 1 |
| Anand-Apte, B | 1 |
| Hollyfield, JG | 1 |
| Samuels, IS | 1 |
| Bullock, JD | 1 |
| Albert, DM | 1 |
2 other studies available for pentobarbital and Retinal Diseases
| Article | Year |
|---|---|
Prolonged ocular exposure leads to retinal lesions in mice.
Topics: Adrenergic alpha-2 Receptor Agonists; Anesthetics, Combined; Anesthetics, Dissociative; Animals; Bio | 2019 |
Generalized oxalosis with retinal involvement following methoxyflurane anesthesia.
Topics: Acute Kidney Injury; Anesthesia, General; Biopsy; Calcium; Humans; Kidney; Male; Metabolic Diseases; | 1974 |